311 related articles for article (PubMed ID: 33631884)
21. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer.
Luo T; Jiang Y; Yang J
Dis Markers; 2021; 2021():1244612. PubMed ID: 34422133
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
26. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
27. Silencing of the long noncoding RNA LINC01132 alleviates the oncogenicity of epithelial ovarian cancer by regulating the microRNA‑431‑5p/SOX9 axis.
Zhu W; Xiao X; Chen J
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132375
[TBL] [Abstract][Full Text] [Related]
28. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
[TBL] [Abstract][Full Text] [Related]
29. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
30. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
32. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
33. Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
Wang S; Zhang L; Tao L; Pang L; Fu R; Fu Y; Liang W; Ding Y; Jia W
Dis Markers; 2020; 2020():9696285. PubMed ID: 32076467
[TBL] [Abstract][Full Text] [Related]
34. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
[TBL] [Abstract][Full Text] [Related]
35. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
[TBL] [Abstract][Full Text] [Related]
36. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
[No Abstract] [Full Text] [Related]
37. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Wu WJ; Shen Y; Sui J; Li CY; Yang S; Xu SY; Zhang M; Yin LH; Pu YP; Liang GY
Mol Med Rep; 2018 Jun; 17(6):7845-7858. PubMed ID: 29620291
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.
Li TH; Zhang JJ; Liu SX; Chen Y
Medicine (Baltimore); 2018 May; 97(19):e0575. PubMed ID: 29742691
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.
Hao W; Zhao H; Li Z; Li J; Guo J; Chen Q; Gao Y; Ren M; Zhao X; Yue W
J Ovarian Res; 2021 Mar; 14(1):46. PubMed ID: 33726773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]